Procter & Gamble topped expectations in fiscal 2025's Q2 with strong revenue figures, but it continues to face challenges with supply chain costs.

Market participants were in full risk-on mode Wednesday as an AI-fueled rally in big tech stocks and a batch of upbeat corporate earnings sent stocks to fresh highs. Tech stocks dominated the list of biggest gainers after President Trump unveiled The Stargate Project,

More consumers are purchasing goods in bulk, the retailer says. It's one way shoppers are coping with lingering inflation anxieties.

Barclays analyst Lauren Lieberman maintained a Hold rating on Procter & Gamble (PG – Research Report) today and set a price target of

Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data centers in the U.S.

(Reuters) -Procter & Gamble beat second-quarter results estimates on Wednesday, driven by growing demand for its household items such as Pantene shampoos and Tide detergents as product innovations acr

Procter & Gamble reported solid quarterly results, boosted by volume growth and higher prices in several key categories in North America. Asked about potential tariffs on U.S. imports—as promised by President Trump—executives said P&G manufactures the vast majority of its products locally.

Procter & Gamble (NYSE:PG), a global leader in consumer goods, continues to navigate a complex market environment characterized by shifting consumer behaviors, currency headwinds, and competitive pressures.

Procter & Gamble PG posted a 3% rise in organic sales on a 2% bump in volumes and a 1% benefit from favorable mix. However, margins contracted, with the firm’s adjusted gross margin down 30 basis points to 52.4% and its adjusted operating margin off 80 basis points to 26.2%.

Oracle stock is higher Wednesday after President Trump announced the $500 billion AI-focused Stargate Project. Here's what you need to know.

Procter & Gamble Hygiene & Healthcare Ltd. key Products/Revenue Segments include Hygiene Products, Creams & Ointments, Cough Drops, Tablets for the year ending 30-Jun-2024.For the quarter ended 30-09-2024, the company has reported a Standalone Total Income ...